Politics and Evidence-Based Practice and Policy TOPIC :Think about a familiar cl


Politics and Evidence-Based Practice and Policy
TOPIC :Think about a familiar clinical practice area where interest groups are attempting to bring about a change in clinical care or systems of service delivery. Assume new, game-changing research finding are published and received wide attention. Identify groups that might have an interest in these finding. What are their likely reactions to new research?
ANSWER TO A answers to THIS PEER with Rationale Healthcare, evidence-based practice, and politics must work together to help people. To promote a good coexistence between policy and healthcare, interest groups bridge the gap and push for improved policies that lessen the burden of care on nurses and improve patient clinical results. This was seen during the Covid-19 pandemic reaction (Junk et al., 2021; Thompson et al., 2020). The Covid-19 pandemic has boosted research and evidence-based research for contagious illnesses. Much study has been done to prevent, decrease, or treat the condition. This work led to game-changing discoveries on disease transmission and control. A method based on evidence used to combat the pandemic has established a precedent for the preparedness and management of future pandemics.
Covid-19 has formed or revitalized several interest organizations. Each interest group has a role to play in preserving its population or bridging disparities between groups like healthcare practitioners and political officials (Hart et al., 2020; Junk et al., 2021). Even while vaccinations exist, new virus types keep developing, giving the health industry restless nights. This has led to consumers taking more dosages than expected and being encouraged to receive more booster injections to minimize their risk of getting new virus types. Assuming new game-changing research lowers the likelihood of viral mutations to zero, this would deliver a tremendous blow to the infection’s propagation. Many interest groups would want to expand this study and use its results in the health sector to help end the spread of the virus.
The COVID-19 Scientific Interest Group, founded in March 2020, would be the most important. In light of the recent study results, the interest group would encourage cooperation and the sharing of information and resources between NIH intramural scientists and their HHS counterparts (NIAID, 2022). According to NIAID (2022), it would be critical to share the findings because of the group’s emphasis on clinical symptoms, medical biomarkers, the long-term impacts of COVID-19, and treatments.
The Association of American Medical Colleges would also play an essential role in the study. The organization and other interest groups collaborate with politicians and other leaders to push policy initiatives that improve the nation’s health and well-being (Thompson et al., 2020). As a result, in the event of the development of research that might help minimize the Covid-19 virus, the AAMC will play a vital role in influencing health care delivery, research, and education to ensure that the results reach their full potential and benefit the public health (AAMC, 2022). The organization is critical to this agreement because its members strive to create a medical research community and advocate an atmosphere conducive to scientific advancements.
References
AAMC. (2022). Advocacy & Policy. https://www.aamc.org/advocacy-policy
Hart, P. S., Chinn, S., & Soroka, S. (2020). Politicization and Polarization in COVID-19 News Coverage. Science Communication, 42(5), 679–697. https://doi.org/10.1177/1075547020950735
Junk, W. M., Crepaz, M., Hanegraaff, M., Berkhout, J., & Aizenberg, E. (2021). Changes in interest group access in times of crisis: no pain, no (lobby) gain. Journal of European Public Policy, 1–21. https://doi.org/10.1080/13501763.2021.1968936
NIAID. (2022, June 24). COVID-19 Scientific Interest Group. NIH: National Institute of Allergy and Infectious Diseases. https://www.niaid.nih.gov/research/covid-19-sig
Thompson, L. K., Znayenko-Miller, T., Gorenstin, D., Rastorguieva, K., Bég, S., Frates, E., & Frates, B. (2020). Leveraging Lifestyle Medicine Interest Groups Through the COVID-19 Pandemic. American Journal of Lifestyle Medicine, 15(2), 140–145. https://doi.org/10.1177/1559827620936595


Leave a Reply